cagrilintide latest research In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintide–semaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results Cagrilintide - 5mg Vial
Cagrilintide 5mg Vial Cagrilintide 10mg Research Peptide Cagri 5mg CAGRILINTIDE (5MG) Cagrilintide (5mg 10mg)
Pay in 4 interest-free payments of $6.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




